Your browser doesn't support javascript.
loading
CRISPR activation enables high-fidelity reprogramming into human pluripotent stem cells.
Sokka, Joonas; Yoshihara, Masahito; Kvist, Jouni; Laiho, Laura; Warren, Andrew; Stadelmann, Christian; Jouhilahti, Eeva-Mari; Kilpinen, Helena; Balboa, Diego; Katayama, Shintaro; Kyttälä, Aija; Kere, Juha; Otonkoski, Timo; Weltner, Jere; Trokovic, Ras.
Afiliação
  • Sokka J; Research Programs Unit, Stem cells and Metabolism and Biomedicum Stem Cell Centre, Faculty of Medicine, University of Helsinki, Helsinki 00014, Finland.
  • Yoshihara M; Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Stockholm 14183, Sweden.
  • Kvist J; Research Programs Unit, Stem cells and Metabolism and Biomedicum Stem Cell Centre, Faculty of Medicine, University of Helsinki, Helsinki 00014, Finland.
  • Laiho L; Research Programs Unit, Stem cells and Metabolism and Biomedicum Stem Cell Centre, Faculty of Medicine, University of Helsinki, Helsinki 00014, Finland.
  • Warren A; Research Programs Unit, Stem cells and Metabolism and Biomedicum Stem Cell Centre, Faculty of Medicine, University of Helsinki, Helsinki 00014, Finland.
  • Stadelmann C; Research Programs Unit, Stem cells and Metabolism and Biomedicum Stem Cell Centre, Faculty of Medicine, University of Helsinki, Helsinki 00014, Finland.
  • Jouhilahti EM; Research Programs Unit, Stem cells and Metabolism and Biomedicum Stem Cell Centre, Faculty of Medicine, University of Helsinki, Helsinki 00014, Finland.
  • Kilpinen H; Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki 00014, Finland; Faculty of Biological and Environmental Sciences, University of Helsinki, Helsinki 00014, Finland; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki 00014, Finland; European
  • Balboa D; Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology, Barcelona 08003, Spain.
  • Katayama S; Research Programs Unit, Stem cells and Metabolism and Biomedicum Stem Cell Centre, Faculty of Medicine, University of Helsinki, Helsinki 00014, Finland; Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Stockholm 14183, Sweden; Folkhälsan Research Center, Helsinki 00290, Finl
  • Kyttälä A; Finnish Institute for Health and Welfare (THL), THL Biobank, Helsinki 00290, Finland.
  • Kere J; Research Programs Unit, Stem cells and Metabolism and Biomedicum Stem Cell Centre, Faculty of Medicine, University of Helsinki, Helsinki 00014, Finland; Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Stockholm 14183, Sweden; Folkhälsan Research Center, Helsinki 00290, Finl
  • Otonkoski T; Research Programs Unit, Stem cells and Metabolism and Biomedicum Stem Cell Centre, Faculty of Medicine, University of Helsinki, Helsinki 00014, Finland; Children's Hospital, Helsinki University Central Hospital, University of Helsinki, Helsinki 00290, Finland.
  • Weltner J; Research Programs Unit, Stem cells and Metabolism and Biomedicum Stem Cell Centre, Faculty of Medicine, University of Helsinki, Helsinki 00014, Finland; Department of Clinical Science, Intervention, and Technology, Karolinska Institutet, Huddinge, Stockholm 14186, Sweden; Division of Obstetrics and
  • Trokovic R; Research Programs Unit, Stem cells and Metabolism and Biomedicum Stem Cell Centre, Faculty of Medicine, University of Helsinki, Helsinki 00014, Finland. Electronic address: ras.trokovic@helsinki.fi.
Stem Cell Reports ; 17(2): 413-426, 2022 02 08.
Article em En | MEDLINE | ID: mdl-35063129
Conventional reprogramming methods rely on the ectopic expression of transcription factors to reprogram somatic cells into induced pluripotent stem cells (iPSCs). The forced expression of transcription factors may lead to off-target gene activation and heterogeneous reprogramming, resulting in the emergence of alternative cell types and aberrant iPSCs. Activation of endogenous pluripotency factors by CRISPR activation (CRISPRa) can reduce this heterogeneity. Here, we describe a high-efficiency reprogramming of human somatic cells into iPSCs using optimized CRISPRa. Efficient reprogramming was dependent on the additional targeting of the embryo genome activation-enriched Alu-motif and the miR-302/367 locus. Single-cell transcriptome analysis revealed that the optimized CRISPRa reprogrammed cells more directly and specifically into the pluripotent state when compared to the conventional reprogramming method. These findings support the use of CRISPRa for high-quality pluripotent reprogramming of human cells.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Reprogramação Celular / Repetições Palindrômicas Curtas Agrupadas e Regularmente Espaçadas / Edição de Genes Limite: Humans Idioma: En Revista: Stem Cell Reports Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Finlândia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Reprogramação Celular / Repetições Palindrômicas Curtas Agrupadas e Regularmente Espaçadas / Edição de Genes Limite: Humans Idioma: En Revista: Stem Cell Reports Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Finlândia